Efficient intracytoplasmic labeling of human umbilical cord blood mesenchymal stromal cells with ferumoxides

Cell Transplantation

Volumn 16, Issue 8, 2007, Pages 849-857

  Jae, Kwon Lee ^a,b   Man, Kyoung Lee ^a   Hye, Jin Jin ^a   Kim, Dal Soo ^a   Yoon, Sun Yang ^a   Oh, Wonil ^a   Yang, Sung Eun ^a   Tae, Seok Park ^c   Soo, Yeol Lee ^c   Kim, Bum Soo ^d   Jeun, Sin Soo ^d  

^a MEDIPOST Co Ltd   (South Korea)

^b Chungbuk National University   (South Korea)

^c Kyung Hee University   (South Korea)

^d The Catholic University of Korea   (South Korea)

Author keywords

Ferumoxides; Mesenchymal stromal cells; Multilineage differentiation; Superparamagnetic iron oxide; Umbilical cord blood

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE;

ADIPOCYTE; APOPTOSIS; ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL LABELING; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSPLANTATION; CYTOPLASM; HUMAN; HUMAN CELL; IN VIVO STUDY; MESENCHYME CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOBLAST; PRIORITY JOURNAL; STROMA CELL; UMBILICAL CORD BLOOD;

EID: 41349104676     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000007783465271     Document Type: Article

References (28)

1. Arbab, A. S.; Bashaw, L. A.; Miller, B. R.; Jordan, E. K.; Bulte, J. W.; Frank, J. A. Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: Methods and techniques. Transplantation 76:1123-1130; 2003.
2. Arbab, A. S.; Bashaw, L. A.; Miller, B. R.; Jordan, E. K.; Lewis, B. K.; Kalish, H.; Frank, J. A. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology 229:838-846; 2003.
3. Arbab, A. S.; Yocum, G. T.; Kalish, H.; Jordan, E. K.; Anderson, S. A.; Khakoo, A. Y.; Read, E. J.; Frank, J. A. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 104:1217-1223; 2004.
4. Bieback, K.; Kern, S.; Kluter, H.; Eichler, H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22:625-634; 2004.
5. Broxmeyer, H. E.; Douglas, G. W.; Hangoc, G.; Cooper, S.; Bard, J.; English, D.; Amy, M.; Thomas, L.; Boyse, E. A. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc. Natl. Acad. Sci. USA 86:28-32; 1989.
6. Broxmeyer, H. E.; Kurtzberg, J.; Gluckman, E.; Auerbach, A. D.; Douglas, G.; Cooper, S.; Falkenburg, J. H.; Bard, J.; Boyse, E. A. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical cord blood from an HLA-identical sibling. N. Engl. J. Med. 321:1174-1178; 1989.
7. Broxmeyer, H. E. Proliferative, self-renewal, and survival characteristics of cord blood hematopoietic stem and progenitor cells. Bethesda, MD: AABB Press; 2004.
8. Campagnoli, C.; Roberts, I. A.; Kumar, S.; Bennett, P. R.; Bellantuono, I.; Fisk, N. M. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98:2396-2402; 2001
9. Chomczynski, P.; Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159; 1987.
10. Frank, J. A.; Miller, B. R.; Arbab, A. S.; Zywicke, H. A.; Jordan, E. K.; Lewis, B. K.; Bryant, Jr., L. H.; Bulte, J. W. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 228:480-487; 2003.
11. Frank, J. A.; Zywicke, H.; Jordan, E. K.; Mitchell, J.; Lewis, B. K.; Miller, B.; Bryant, Jr., L. H.; Bulte, J. W. Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. Acad. Radiol. 2:484-487; 2002.
12. Gimble, J. M.; Robinson, C. E.; Wu, X.; Kelly, K. A. The function of adipocytes in the bone marrow stroma: An update. Bone 19:421-428; 1996.
13. Glukman, E. Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp. Hematol. 28:1197-1205; 2000.
14. Goodwin, H. S.; Bicknese, A. R.; Chien, S. N.; Bogucki, B. D.; Quinn, C. O.; Wall, D. A. Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers. Biol. Blood Marrow Transplant. 7:581-588; 2001.
15. Kato, S.; Nishihira, H.; Hara, H.; Kato, S.; Nishihira, H.; Hara, H.; Kato, K.; Takahashi, T.; Sato, N.; Kodera, Y.; Saito, H.; Sato, H.; Takanashi, M. Cord blood transplantation and cord blood banking in Japan. Bone Marrow Transplant. 25:68-70; 2000.
16. Kostura, L.; Kraitchman, D. L.; Mackay, A. M.; Pittenger, M. F.; Bulte, J. W. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed. 17:513-517; 2004.
17. Laughlin, M. J. Umbilical cord blood for allogeneic transplantation in children and adults. Bone Marrow Transplant. 27:1-6; 2001.
18. Laughlin, M. J.; Barker, J.; Bambach, B.; Laughlin, M. J.; Barker, J.; Bambach, B.; Koc, O. N.; Rizzieri, D. A.; Wagner, J. E.; Gerson, S. L.; Lazarus, H. M.; Cairo, M.; Stevens, C. E.; Rubinstein, P.; Kurtzberg, J. Hematopoietic engraftment and survival in adult recipients of umbilical cord blood from unrelated donors. N. Engl. J. Med. 344:1815-1822; 2001.
19. Le Blanc, K.; Tammik, L.; Sundberg, B.; Haynesworth, S. E.; Ringden, O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand. J. Immunol. 57:11-20; 2003.
20. Lee, J. K.; Kim, S-H.; Lewis, E. C.; Azam, T.; Reznikov, L. L.; Dinarello, C. A. Differences in signaling pathways by IL-1β and IL-18. Proc. Natl. Acad. Sci. USA 101:8815-8820; 2004.
21. Lu, P.; Blesch, A.; Tuszynski, M. H. Induction of bone marrow stromal cells to neurons: Differentiation, transdifferentiation, or artifact? J. Neurosci. Res. 77:174-191; 2004.
22. Newcomb, J. D.; Ajmo, Jr., C. T.; Sanberg, C. D.; Sanberg, P. R.; Pennypacker, K. R.; Willing, A. E. Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplant. 15:213-223; 2006.
23. Ourednik, J.; Ourednik, V.; Lynch, W. P.; Schachner, M.; Snyder, E. Y. Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat. Biotechnol. 20:1103-1110; 2002.
24. Rubinstein, P.; Carrier, C.; Scaradavou, A.; Kurtzberg, J.; Adamson, J.; Migliaccio, A. R.; Berkowitz, R. L.; Cabbad, M.; Dobrila, N. L.; Taylor, P. E.; Rosenfield, R. E.; Stevens, C. E. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N. Engl. J. Med. 339:1565-1577; 1998.
25. Studer, L.; Tabar, V.; McKay, R. D. Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat. Neurosci. 1:290-295; 1998.
26. Swanger, S. A.; Neuhuber, B.; Himes, B. T.; Bakshi, A.; Fischer, I. Analysis of allogeneic and syngeneic bone marrow stromal cell graft survival in the spinal cord. Cell Transplant. 14:775-786; 2005.
27. Walczak, P.; Kedziorek, D. A.; Gilad, A. A.; Lin, S.; Bulte, J. W. Instant MR labeling of stem cells using magnetoelectroporation. Magn. Reson. Med. 54:769-774; 2005.
28. Yang, S. E.; Ha, C. W.; Jung, M. H.; Jin, H. J.; Lee, M. K.; Song, H. S.; Choi, S. J.; Oh, W.; Yang, Y. S. Mesenchymal stem/progenitor cells developed in cultures from UC blood. Cytotherapy 6:476-486; 2004.